RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
1-Year Return
18.15%
This Quarter Return
+29.99%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$815M
AUM Growth
+$109M
(+16%)
Cap. Flow
+$2.19M
Cap. Flow
% of AUM
0.27%
Top 10 Holdings %
Top 10 Hldgs %
85.95%
Holding
32
New
5
Increased
2
Reduced
5
Closed
8
Top Buys
| 1 |
Esperion Therapeutics
ESPR
|
$24.9M |
| 2 |
LOXO
Loxo Oncology, Inc
LOXO
|
$12.6M |
| 3 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$10.3M |
| 4 |
MYOV
Myovant Sciences Ltd.
MYOV
|
$9.96M |
| 5 |
RXDX
Ignyta, Inc.
RXDX
|
$8.82M |
Top Sells
| 1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$20.2M |
| 2 |
Ardelyx
ARDX
|
$14M |
| 3 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$13.9M |
| 4 |
Abeona Therapeutics
ABEO
|
$5.54M |
| 5 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
$5.47M |
Sector Composition
| 1 | Healthcare | 97.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKTX
26
Akari Therapeutics
AKTX
$23.8M
| – | – |
-5,072
| Closed | -$714K |
|
27
Tenax Therapeutics
TENX
$27.4M
| – | – |
-75
| Closed | -$4.66M |
|
|
ORKA
28
Oruka Therapeutics, Inc. Common Stock
ORKA
$561M
| – | – |
-1,075
| Closed | -$662K |
|
|
ACGN
29
DELISTED
Aceragen, Inc. Common Stock
ACGN
| – | – |
-16,561
| Closed | -$3.38M |
|
|
SBBP
30
DELISTED
Strongbridge Biopharma plc.
SBBP
| – | – |
-2,279,099
| Closed | -$5.47M |
|
|
AIMT
31
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| – | – |
-677,663
| Closed | -$13.9M |
|
|
DMTX
32
DELISTED
Dimension Therapeutics, Inc
DMTX
| – | – |
-928,199
| Closed | -$4.04M |
|